Patent · US Active

Secnidazole for use in the treatment of bacterial vaginosis

US10335390B2 · kind B2 · utility

2Cited by
40References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 4, 2015
Grant dateJul 2, 2019
Priority date—
Expiry dateSep 4, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D233/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.